A novel variant of RyR2 gene in a family misdiagnosed as congenital long QT syndrome: The importance of genetic testing

J Electrocardiol. 2020 May-Jun:60:8-11. doi: 10.1016/j.jelectrocard.2020.03.001. Epub 2020 Mar 5.

Abstract

Catecholaminergic polymorphic ventricular tachycardia (CPVT) and Long-QT syndrome (LQTS) are two distinct entities with similar clinical presentation and management but different clinical course. In this study, we present two family members presented with aborted sudden cardiac death (SCD) that was attributed to CPVT. The CPVT may be underrecognized in SCD victims and a diagnosis of "atypical LQTS" may warrant consideration of CPVT and analysis of RyR2 if the standard cardiac channel gene screen for LQTS is negative. Although the management of both channelopathies is quite common the clinical outcomes are different, with CPVT displaying a more malignant clinical course.

Keywords: Cardiac arrest; Catecholaminergic polymorphic ventricular tachycardia; Channelopathies; Long-QT syndrome.

Publication types

  • Case Reports

MeSH terms

  • Diagnostic Errors
  • Electrocardiography
  • Genetic Testing
  • Humans
  • Long QT Syndrome* / diagnosis
  • Long QT Syndrome* / genetics
  • Ryanodine Receptor Calcium Release Channel / genetics
  • Tachycardia, Ventricular* / diagnosis
  • Tachycardia, Ventricular* / genetics

Substances

  • Ryanodine Receptor Calcium Release Channel